Neurologist and Duke ALS Clinic Director Richard Bedlack “stitches strength” for his patients, showing the powers of hope.

Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose ...

Inhibition of a cellular stress response may be a therapeutic target for ALS type 8 related to mutations in the VAPB gene, a ...

Amylyx Pharmaceuticals, Inc. (($AMLX)) announced an update on their ongoing clinical study. Amylyx Pharmaceuticals, Inc. is conducting a Phase 1 ...

Eric Dane revealed he's been diagnosed with amyotrophic lateral sclerosis, also known as ALS. Here's what to know about the rare disease.

TMTPOST -- Synchron Inc. has publicly demonstrated the world’s first successful control of Apple devices — including the iPad ...